
About
Exiris is a preclinical-stage company in Rome, Italy focused on oncology target discovery and development of therapeutic agents for cancer indications with high unmet medical need. It provides contract research and collaborative development services to pharmaceutical companies, biotechs, and academic groups, using its own platforms for cancer stem cells, target identification, drug conjugates, antibody technologies, biomarker discovery, and drug development.
Services
CSC Platform
Uses a cancer stem cell platform for target identification and validation.
Target ID
Supports target identification and validation through platform technologies.
Drug Conjugate Platform
Develops antibody or peptide conjugation approaches for therapeutic drug conjugates.
Custom human mAb production
Produces custom human monoclonal antibodies.
Biomarker discovery
Discovers or validates biomarkers using follicle and skin-equivalent-based workflows.
Drug development
Provides preclinical drug discovery and development support for oncology projects.
Human or mouse hair follicle biomarker analysis
Validates or discovers biomarkers in plucked human or mouse hair follicles with mRNA extraction and TaqMan qRT-PCR.
Human skin equivalent biomarker discovery
Discovers skin biomarkers in human skin equivalent cultures.
Medium scale compound testing
Performs medium-scale testing of compounds for drug discovery programs.
Enzyme assay setup and validation
Sets up and validates enzyme assays.
Cell-based reporter assay development
Develops cell-based reporter assays.
Stable transfected cell clone selection
Selects stable transfected cell clones.
Capabilities
- Assays and studies
- Antibodies · ADCs · In vivo · Bispecifics · Rodent models · Peptides · mRNA · Target identification · Target validation · Biomarker discovery · mRNA extraction · qRT-PCR
4 more
TaqMan qRT-PCR · Medium scale compound testing · Enzyme assays · Cell-based reporter assays - Therapeutic areas
- Oncology · Cancer
Instruments and platforms
- TaqMan qRT-PCR
Modalities and species
- Modalities
- Antibody · Bispecific · ADC · Peptide · mRNA
- Species and models
- Human · Mouse · Primary tumor models · Cancer stem cell models · Transgenic animals · Human skin equivalents · Human or mouse hair follicles
Company
- Type
- CRO
- Founded
- 2010
Locations
- Based in
- Rome, Italy
- Sites
- Rome, Italy
- Serves
- Italy
Contacts
- General enquiry
- info@exiris.it on their site
Similar labs
Work here? Claim this listing